Key facts
- This page summarizes SZOSTAK M ANNE's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 May 2026, 17:10.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares held by the Trust.
Footnote F2
The reporting person is a trustee of The O'Hanian-Szostak Family Foundation ('Foundation') and has power to direct the distribution of assets held by the Foundation.
Footnote F3
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026.
Footnote F4
Not applicable.